中文簡(jiǎn)介：

深圳天緣醫藥科技有限公司，是一家致力于為全球醫藥行業(yè)提供全方位服務(wù)的高科技企業(yè)。自成立以來(lái)，我們始終堅持以科技創(chuàng )新為核心，以滿(mǎn)足客戶(hù)需求為導向，為全球醫藥企業(yè)提供從藥物發(fā)現到生產(chǎn)過(guò)程的一體化解決方案。我們的業(yè)務(wù)范圍覆蓋了藥物研發(fā)、生產(chǎn)、銷(xiāo)售、技術(shù)支持等多個(gè)領(lǐng)域，為客戶(hù)提供全方位的服務(wù)支持。

我們的研發(fā)團隊擁有世界一流的科研實(shí)力，匯集了眾多國內外的藥物研發(fā)專(zhuān)家和技術(shù)骨干。在藥物研發(fā)過(guò)程中，我們秉持創(chuàng )新、高效、安全的原則，采用先進(jìn)的技術(shù)手段和設備，充分發(fā)揮團隊的專(zhuān)業(yè)優(yōu)勢，為客戶(hù)提供高質(zhì)量的藥物研發(fā)服務(wù)。在生物藥物的研發(fā)和生產(chǎn)過(guò)程中，我們采用了一系列創(chuàng )新技術(shù)和方法，有效地簡(jiǎn)化了生產(chǎn)流程，提高了生產(chǎn)效率，降低了生產(chǎn)成本，為客戶(hù)帶來(lái)了顯著(zhù)的經(jīng)濟效益。

我們的質(zhì)量管理體系已通過(guò)FDA（美國食品藥品監督管理局）、EMA（歐洲藥品管理局）和NMPA（國家藥品監督管理局）的認證，充分體現了我們在質(zhì)量管理方面的嚴謹態(tài)度和高標準要求。為了更好地服務(wù)客戶(hù)，我們在深圳前海自貿區投資建設了一座多功能醫藥研發(fā)中心，提供從藥物篩選、藥物設計、藥物合成、藥物評價(jià)等全過(guò)程的一站式服務(wù)。

在治療重大疾病領(lǐng)域，我們取得了一系列令人矚目的成果。在抗病毒、腫瘤、代謝、心血管等領(lǐng)域，我們憑借強大的研發(fā)實(shí)力和豐富的行業(yè)經(jīng)驗，為全球醫藥企業(yè)研發(fā)了眾多高效、安全的創(chuàng )新藥物。尤其在替尼藥物方面，我們擁有無(wú)與倫比的能力和專(zhuān)業(yè)知識，為全球醫藥企業(yè)提供了高質(zhì)量的替尼藥物研發(fā)服務(wù)。

作為一家國際化的醫藥科技企業(yè)，我們與全球3200多家合作伙伴建立了良好的合作關(guān)系，為客戶(hù)提供了全球范圍內的業(yè)務(wù)支持和服務(wù)。在商業(yè)化藥物開(kāi)發(fā)過(guò)程中，我們始終堅持“真正的一站式”理念，為客戶(hù)提供從藥物研發(fā)、生產(chǎn)、銷(xiāo)售到技術(shù)支持等全方位的服務(wù)，幫助客戶(hù)實(shí)現藥物的快速上市和商業(yè)化。

展望未來(lái)，深圳天緣醫藥科技有限公司將繼續堅持創(chuàng )新驅動(dòng)、科技領(lǐng)先的發(fā)展戰略，加大研發(fā)投入，不斷提升技術(shù)水平和服務(wù)質(zhì)量，為全球醫藥行業(yè)的發(fā)展做出更大的貢獻。我們將與全球合作伙伴共同努力，為人類(lèi)健康事業(yè)的發(fā)展貢獻智慧和力量，為創(chuàng )造美好的未來(lái)而不懈努力。

英文簡(jiǎn)介：

Shenzhen Tianyuan Pharmaceutical Technology Co., Ltd. is a high-tech enterprise dedicated to providing a full range of services for the global pharmaceutical industry.

Since its inception, we have always adhered to scientific and technological innovation as the core, to meet customer needs as the orientation, to provide global pharmaceutical companies with integrated solutions from drug discovery to production process.

Our business scope covers drug research and development, production, sales, technical support and other areas, to provide customers with a full range of service support.

Our R & D team has world-class scientific research strength and brings together many top drug R & D experts and technical backbones at home and abroad.

In the process of drug research and development, we adhere to the principles of innovation, efficiency and safety, adopt advanced technical means and equipment, give full play to the professional advantages of the team, and provide customers with high-quality drug research and development services.

In the process of R & D and production of biopharmaceuticals, we have adopted a series of innovative technologies and methods to effectively simplify the production process, improve production efficiency, reduce production costs, and bring significant economic benefits to customers.

Our quality management system has been certified by FDA (US Food and Drug Administration), EMA (European Drug Administration) and NMPA (State Drug Administration), which fully reflects our stringent attitude and high standards in quality management.

In order to better serve our customers, we have invested in building a multi-functional pharmaceutical R & D center in Qianhai Free Trade Zone in Shenzhen, providing one-stop services for the whole process of drug screening, drug design, drug synthesis, drug evaluation and so on.

In the field of treating major diseases, we have made a series of remarkable achievements.

With our strong R & D strength and rich industry experience, we have developed many efficient and safe innovative drugs for global pharmaceutical companies in the fields of antiviral, oncology, metabolism, cardiovascular and so on.

Especially in the field of tini drugs, we have unparalleled ability and expertise to provide high-quality tini drug research and development services for global pharmaceutical companies.

As an international pharmaceutical technology enterprise, we have established a good cooperative relationship with more than 3200 partners around the world to provide customers with global business support and services.

In the process of commercial drug development, we always adhere to the "real one-stop" concept, providing customers with a full range of services from drug research and development, production, sales to technical support, to help customers achieve rapid drug marketing and commercialization.

Looking to the future, Shenzhen Tianyuan Pharmaceutical Technology Co., Ltd. will continue to adhere to the innovation-driven and technology-leading development strategy, increase R & D investment, constantly improve the technical level and service quality, and make greater contributions to the development of the global pharmaceutical industry.

We will make joint efforts with global partners to contribute wisdom and strength to the development of human health and make unremitting efforts to create a better future.

關(guān)鍵詞：

英文：Filgotinib maleate,Pralsetinib (BLU-667),Pemigatinib,TIC10,Sodium phenylbutyrate,Mirogabalin besylate,Tyk2-IN-4(BMS986165),Ribociclib,Dotinurad,2,6-Bis(hydroxymethyl)-p-cresol,Brincidofovir,Finerenone,Peficitinib,Ticagrelor,Vonoprazan Fumarate (TAK-438),Sacubitril/valsartan (LCZ696),Upadacitinib,Tofacitinib (CP-690550) Citrate

中文：

非戈替尼、拉西替尼（BLU-667）、培米加替尼、onc201（TIC10）、4-苯基丁酸鈉鹽、米洛巴林、氘可來(lái)替尼（BMS-986165）、瑞博西尼（LEE011）、多替諾德、布羅福韋酯（CMX001）、2-羥基-5-甲基間苯二甲醇、非奈利酮、培菲替尼、替卡格雷、富馬酸沃諾拉贊、沙卡布曲纈沙坦（LCZ696）、烏帕替尼、托法替尼